Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Breast cancer grade and stage do not affect fertility preservation outcomes.
Journal: Journal of assisted reproduction and genetics
Published: January 13, 2022
Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
Journal: Journal of assisted reproduction and genetics
Published: March 12, 2021
Changing stimulation protocol on repeat conventional ovarian stimulation cycles does not lead to improved laboratory outcomes.
Journal: Fertility and sterility
Published: January 24, 2021
Uterine synechiae after intrauterine device use: a case series.
Journal: Journal of assisted reproduction and genetics
Published: December 17, 2020
Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients.
Journal: Journal of assisted reproduction and genetics
Published: September 10, 2020
High incidence of diminished ovarian reserve in young unexplained recurrent pregnancy loss patients.
High incidence of diminished ovarian reserve in young unexplained recurrent pregnancy loss patients.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: April 14, 2020
Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations.
Journal: Journal of assisted reproduction and genetics
Published: May 24, 2019
Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
Journal: Journal of assisted reproduction and genetics
Published: February 08, 2019
mTOR inhibitor sirolimus negatively impacts in vitro fertilization outcomes.
Journal: Journal of assisted reproduction and genetics
Published: December 18, 2018
Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
Journal: Journal of assisted reproduction and genetics
Published: February 13, 2018
Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Journal: Human reproduction (Oxford, England)
Published: May 24, 2017
Last Updated: 09/26/2026